Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

Smithfield Foods could be one of the year's biggest U.S. initial public offerings, with the pork producer planning to raise as much as $940 million as it returns to the stock market.

Skyline Builders Group Holding Limited (NASDAQ: SKBL), a Hong Kong-based public works contractor, launched its initial public ...

Shares of Hong Kong Pharma Digital Technology (NASDAQ:HKPD), a provider of OTC pharmaceutical cross-border services, were ...

The Inner Mongolia-based maker of carbonated beverages, juices and protein drinks is working with advisers on the size and ...

EcoCeres Inc., a producer of sustainable fuel backed by Bain Capital, is exploring an initial public offering that could ...

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...

Seven IPOs and one SPAC priced this past week, as more sizable issuers filed to go public in the US. Read more here.

Shares of Ascentage Pharma Group International pared earlier losses to rise 0.75% in the Chinese biopharmaceutical company’s ...

Ascentage is looking to use the IPO proceeds to advance its Phase III candidates for chronic or small lymphocytic leukemia ...

A global biopharma with a U.S. headquarters in Montgomery County is gearing up to go public on a U.S. exchange.

Venture Global’s stock fell about 4% below its initial public offering price in its market debut on Friday, after the liquefied natural gas ...